Abbott Laboratories Stock Profit Margin
| ABTT34 Stock | BRL 57.00 0.12 0.21% |
Abbott Laboratories fundamentals help investors to digest information that contributes to Abbott Laboratories' financial success or failures. It also enables traders to predict the movement of Abbott Stock. The fundamental analysis module provides a way to measure Abbott Laboratories' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Abbott Laboratories stock.
Abbott |
Abbott Laboratories Company Profit Margin Analysis
Abbott Laboratories' Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Abbott Laboratories Profit Margin | 0.16 % |
Most of Abbott Laboratories' fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Abbott Laboratories is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, Abbott Laboratories has a Profit Margin of 0.1588%. This is 101.42% lower than that of the Healthcare sector and 102.91% lower than that of the Medical Devices industry. The profit margin for all Brazil stocks is 112.5% lower than that of the firm.
Abbott Profit Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Abbott Laboratories' direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Abbott Laboratories could also be used in its relative valuation, which is a method of valuing Abbott Laboratories by comparing valuation metrics of similar companies.Abbott Laboratories is currently under evaluation in profit margin category among its peers.
Abbott Fundamentals
| Return On Equity | 0.19 | |||
| Return On Asset | 0.0882 | |||
| Profit Margin | 0.16 % | |||
| Operating Margin | 0.20 % | |||
| Current Valuation | 1.07 T | |||
| Shares Outstanding | 20.92 B | |||
| Price To Earning | 40.47 X | |||
| Price To Book | 5.41 X | |||
| Price To Sales | 22.38 X | |||
| Revenue | 43.65 B | |||
| Gross Profit | 24.68 B | |||
| EBITDA | 10.69 B | |||
| Net Income | 6.93 B | |||
| Cash And Equivalents | 8.37 B | |||
| Cash Per Share | 1.18 X | |||
| Total Debt | 17.3 B | |||
| Debt To Equity | 0.55 % | |||
| Current Ratio | 1.75 X | |||
| Book Value Per Share | 5.12 X | |||
| Cash Flow From Operations | 10.53 B | |||
| Earnings Per Share | 1.69 X | |||
| Price To Earnings To Growth | 18.67 X | |||
| Number Of Employees | 115 K | |||
| Beta | 0.65 | |||
| Market Capitalization | 1 T | |||
| Total Asset | 75.2 B | |||
| Z Score | 34.2 | |||
| Annual Yield | 0.02 % | |||
| Five Year Return | 1.67 % | |||
| Net Asset | 75.2 B | |||
| Last Dividend Paid | 1.92 |
About Abbott Laboratories Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Abbott Laboratories's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Abbott Laboratories using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Abbott Laboratories based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Information and Resources on Investing in Abbott Stock
When determining whether Abbott Laboratories is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Abbott Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Abbott Laboratories Stock. Highlighted below are key reports to facilitate an investment decision about Abbott Laboratories Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abbott Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For information on how to trade Abbott Stock refer to our How to Trade Abbott Stock guide.You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.